MARK CLARKE: Open Payments
NPI 1790850584 · SMITHFIELD, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,652 in 247 payments from 32 companies in 2025. Trend: 2023 $8,090 · 2024 $7,367 · 2025 $7,652
Food & beverage: $7,652
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $1,536 |
| PFIZER INC. | 28 | $735 |
| Lundbeck LLC | 27 | $731 |
| ABBVIE INC. | 15 | $717 |
| Abbott Laboratories | 8 | $483 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $339 |
| Axsome Therapeutics, Inc. | 12 | $323 |
| GlaxoSmithKline, LLC. | 13 | $321 |
| Novo Nordisk Inc | 12 | $263 |
| Amgen Inc. | 9 | $256 |
Products named: AIRSUPRA, VRAYLAR, VYEPTI, JARDIANCE, NURTEC ODT, FREESTYLE LIBRE 3, Auvelity, FARXIGA.
Industry payments across RI — which companies pay providers there.
